Legend Biotech (LEGN) Competitors $34.08 +0.06 (+0.18%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends LEGN vs. TEVA, BGNE, MRNA, VTRS, SMMT, GMAB, RDY, SRPT, CTLT, and PCVXShould you be buying Legend Biotech stock or one of its competitors? The main competitors of Legend Biotech include Teva Pharmaceutical Industries (TEVA), BeiGene (BGNE), Moderna (MRNA), Viatris (VTRS), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Sarepta Therapeutics (SRPT), Catalent (CTLT), and Vaxcyte (PCVX). These companies are all part of the "pharmaceutical products" industry. Legend Biotech vs. Teva Pharmaceutical Industries BeiGene Moderna Viatris Summit Therapeutics Genmab A/S Dr. Reddy's Laboratories Sarepta Therapeutics Catalent Vaxcyte Legend Biotech (NASDAQ:LEGN) and Teva Pharmaceutical Industries (NYSE:TEVA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings. Is LEGN or TEVA more profitable? Teva Pharmaceutical Industries has a net margin of -5.73% compared to Legend Biotech's net margin of -66.92%. Teva Pharmaceutical Industries' return on equity of 42.92% beat Legend Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Legend Biotech-66.92% -29.69% -19.45% Teva Pharmaceutical Industries -5.73%42.92%7.25% Which has higher earnings & valuation, LEGN or TEVA? Legend Biotech has higher earnings, but lower revenue than Teva Pharmaceutical Industries. Legend Biotech is trading at a lower price-to-earnings ratio than Teva Pharmaceutical Industries, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLegend Biotech$520.18M11.97-$518.25M-$0.95-35.87Teva Pharmaceutical Industries$16.77B1.49-$559M-$0.85-25.99 Do analysts recommend LEGN or TEVA? Legend Biotech currently has a consensus price target of $81.54, suggesting a potential upside of 139.26%. Teva Pharmaceutical Industries has a consensus price target of $20.88, suggesting a potential downside of 5.50%. Given Legend Biotech's stronger consensus rating and higher probable upside, research analysts clearly believe Legend Biotech is more favorable than Teva Pharmaceutical Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Legend Biotech 0 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 3.00Teva Pharmaceutical Industries 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75 Do insiders & institutionals have more ownership in LEGN or TEVA? 70.9% of Legend Biotech shares are owned by institutional investors. Comparatively, 54.0% of Teva Pharmaceutical Industries shares are owned by institutional investors. 0.0% of Legend Biotech shares are owned by insiders. Comparatively, 0.6% of Teva Pharmaceutical Industries shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community believe in LEGN or TEVA? Teva Pharmaceutical Industries received 1244 more outperform votes than Legend Biotech when rated by MarketBeat users. However, 71.55% of users gave Legend Biotech an outperform vote while only 67.81% of users gave Teva Pharmaceutical Industries an outperform vote. CompanyUnderperformOutperformLegend BiotechOutperform Votes8371.55% Underperform Votes3328.45% Teva Pharmaceutical IndustriesOutperform Votes132767.81% Underperform Votes63032.19% Does the media favor LEGN or TEVA? In the previous week, Teva Pharmaceutical Industries had 20 more articles in the media than Legend Biotech. MarketBeat recorded 27 mentions for Teva Pharmaceutical Industries and 7 mentions for Legend Biotech. Teva Pharmaceutical Industries' average media sentiment score of 0.61 beat Legend Biotech's score of 0.49 indicating that Teva Pharmaceutical Industries is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Legend Biotech 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Teva Pharmaceutical Industries 10 Very Positive mention(s) 3 Positive mention(s) 9 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, LEGN or TEVA? Legend Biotech has a beta of 0.08, indicating that its stock price is 92% less volatile than the S&P 500. Comparatively, Teva Pharmaceutical Industries has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. SummaryTeva Pharmaceutical Industries beats Legend Biotech on 11 of the 18 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LEGN vs. The Competition Export to ExcelMetricLegend BiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.22B$6.58B$5.13B$9.07BDividend YieldN/A2.99%5.08%4.23%P/E Ratio-35.8710.5489.7417.18Price / Sales11.97195.791,116.12116.95Price / CashN/A57.1642.8237.86Price / Book4.955.094.774.78Net Income-$518.25M$151.83M$120.15M$225.60M7 Day Performance-2.96%-2.13%-1.92%-1.23%1 Month Performance-14.26%-3.10%11.47%3.36%1 Year Performance-43.24%11.54%30.52%16.60% Legend Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LEGNLegend Biotech1.548 of 5 stars$34.08+0.2%$81.54+139.3%-43.2%$6.22B$520.18M-35.871,800TEVATeva Pharmaceutical Industries1.8881 of 5 stars$16.66+1.0%$19.67+18.0%+112.2%$18.87B$16.77B-19.7937,851Analyst DowngradeOptions VolumeNews CoverageBGNEBeiGene2.6145 of 5 stars$176.52-1.6%$253.69+43.7%+0.7%$17.20B$2.46B-21.7710,600MRNAModerna4.2706 of 5 stars$41.59-0.6%$79.50+91.2%-54.3%$16.00B$5.06B-7.195,600Analyst DowngradeVTRSViatris2.056 of 5 stars$12.71+0.6%$13.67+7.5%+19.8%$15.17B$15.05B-17.0738,000News CoverageSMMTSummit Therapeutics3.2703 of 5 stars$18.71+4.9%$33.33+78.2%+636.9%$13.80B$700,000.00-63.68105News CoverageGap DownGMABGenmab A/S4.2345 of 5 stars$20.14-0.1%$45.20+124.4%-33.5%$13.33B$19.84B19.582,204Positive NewsHigh Trading VolumeRDYDr. Reddy's Laboratories1.86 of 5 stars$14.75+2.0%$17.00+15.3%+15.8%$12.31B$299.87B22.9527,048Analyst DowngradeNews CoverageGap UpSRPTSarepta Therapeutics4.8145 of 5 stars$126.12+1.9%$178.71+41.7%+31.8%$12.05B$1.64B98.971,314Analyst ForecastCTLTCatalent2.7663 of 5 stars$63.48+0.7%$63.40-0.1%N/A$11.52B$4.38B-27.9116,900High Trading VolumePCVXVaxcyte1.6009 of 5 stars$90.59+3.3%$147.50+62.8%+45.4%$11.29BN/A-19.07160Analyst ForecastInsider Trade Related Companies and Tools Related Companies TEVA Alternatives BGNE Alternatives MRNA Alternatives VTRS Alternatives SMMT Alternatives GMAB Alternatives RDY Alternatives SRPT Alternatives CTLT Alternatives PCVX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LEGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LEGN Stock Alerts